# Thyrotoxicosis Management

> Thyrotoxicosis and Graves disease management — antithyroid drugs, radioiodine, surgery, agranulocytosis for NEET-PG Medicine exam preparation.

- Canonical URL: https://prepelephant.com/topics/neet-pg/medicine/thyrotoxicosis-management
- Exam / course: NEET-PG · Subject: Medicine
- Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team
- First published: 2026-10-02
- Last updated: 2026-10-02
- How to cite: "Thyrotoxicosis Management", PrepElephant, https://prepelephant.com/topics/neet-pg/medicine/thyrotoxicosis-management

## Direct answer

Graves' disease — diffuse goitre, orbitopathy, and TSH-receptor antibodies — accounts for most thyrotoxicosis, and its three definitive routes are antithyroid drugs (carbimazole or methimazole, 12–18 months, remission in roughly 40–50%), radioactive iodine (definitive, contraindicated in pregnancy and breastfeeding, can flare orbitopathy), and surgery (large goitres, suspicion of malignancy, drug intolerance). Propylthiouracil is reserved for the first trimester of pregnancy and thyroid storm. The emergency to know cold is agranulocytosis: any patient on thionamides developing fever or sore throat stops the drug and gets an urgent blood count. Orbitopathy management runs in parallel — smoking cessation, selenium, and urgent glucocorticoids for sight-threatening disease — because correcting thyrotoxicosis wrongly (or with radioiodine, in active eye disease) can worsen the eyes.

## What you must remember

- Cause before therapy: Graves' (TRAb positive, diffuse goitre, orbitopathy, pretibial myxoedema), toxic multinodular goitre, toxic adenoma, thyroiditis (depleted stores — thionamides useless), amiodarone, and factitious ingestion.
- Carbimazole/methimazole: 10–20 mg starting doses, either titrated or block-and-replace (30–45 mg plus levothyroxine — never in pregnancy); duration 12–18 months.
- Agranulocytosis: fever or sore throat on thionamides = stop drug, urgent total neutrophil count; classically within the first 3 months. PTU additionally carries hepatotoxicity — the reason it is not first choice outside pregnancy/storm.
- Radioiodine: highly effective, outpatient in most settings; contraindicated in pregnancy, breastfeeding, and with active moderate-to-severe orbitopathy; hypothyroidism is the expected endpoint, not a complication.
- Surgery: total thyroidectomy for large compressive goitres, suspicious nodules coexisting with thyrotoxicosis, pregnancy when drugs fail (second trimester), and patient choice; prepare patients to euthyroidism first.
- Graves' orbitopathy: stop smoking (the single strongest modifiable factor); selenium in mild disease; high-dose glucocorticoids (± urgent decompression) for dysthyroid optic neuropathy or corneal breakdown.
- Pregnancy: PTU in the first trimester, switch (or continue) per specialist practice; target free T4 at or just above the upper reference — over-treatment causes fetal hypothyroidism; block-replace regimens are avoided.

## Working through the three routes with one patient

A 29-year-old woman presents with three months of palpitations, heat intolerance, 5 kg loss, and a diffusely enlarged, bruit-bearing thyroid with mild lid lag; TSH <0.01 mIU/L, free T4 high, TRAb strongly positive. Graves' disease. Propranolol 20–40 mg tapers the symptoms this week; carbimazole 20 mg daily (titrated) begins the real therapy. She smokes — that conversation happens today, both for remission odds and because her mild eye signs make radioiodine a riskier future choice.

If she relapses a year later, radioiodine becomes reasonable — eyes quiet, smoking stopped — while active orbitopathy would favour continued thionamides or surgery, and a large compressive goitre or suspicious nodule swings the decision to surgery.

Now the pregnancy variant: the same patient conceives while on carbimazole. In the first trimester she switches to PTU, because carbimazole/methimazole carry reported embryopathy (aplasia cutis, choanal atresia); block-replace remains contraindicated. TRAb crosses the placenta in late pregnancy, mandating fetal surveillance; free T4 is held at the upper-normal line, since over-treating the mother under-treats the fetus.

## Where students slip

First, prescribing thionamides for thyroiditis: destructive release of stored hormone involves no synthesis to block — beta-blockade and patience are the therapy. Second, missing the agranulocytosis rule — every thionamide patient leaves knowing that fever or sore throat means an immediate count, not a wait-and-watch. Third, forgetting that PTU's liver risk caps its use (first trimester and storm), a balance-point examiners test directly. Fourth, offering radioiodine to the pregnant or breastfeeding patient — an absolute contraindination — or to a smoker with active orbitopathy without glucocorticoid cover. Finally, in storm-level thyrotoxicosis, sequencing errors: PTU, iodine (an hour after thionamide), beta-blocker, glucocorticoids and cooling act together; iodine given before the thionamide feeds hormone synthesis — order matters.

## Frequently asked questions

### What are the first-line drugs for Graves' disease and for how long?

Carbimazole (or methimazole), either titrated to the lowest controlling dose or as block-and-replace, continued 12–18 months; remission follows in roughly 40–50%, with relapse risk highest in the first year afterward and in smokers.

### When is propylthiouracil preferred over carbimazole?

In the first trimester of pregnancy (lower reported teratogenicity) and in thyroid storm (it blocks peripheral T4-to-T3 conversion); elsewhere its hepatotoxicity and thrice-daily dosing make it second line.

### What immediate advice is given about fever or sore throat on thionamides?

Stop the drug and get an urgent blood count — agranulocytosis is the feared idiosyncratic reaction, concentrated in the first months of therapy; a neutrophil count below about 0.5 × 10^9/L confirms it and mandates a different definitive strategy.

### How does radioactive iodine fit into management?

As a definitive, usually outpatient option for Graves' disease and toxic nodular goitres — expected hypothyroidism follows — contraindicated in pregnancy and breastfeeding, and used cautiously with glucocorticoid cover in active orbitopathy.

### How is thyrotoxicosis managed in pregnancy?

PTU in the first trimester at the lowest dose keeping free T4 at or slightly above the upper reference limit, switching agents later per specialist practice, with block-replace regimens avoided and TRAb measured in the third trimester to assess fetal risk.